secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexentis Technologies Inc. (NXTS)
CIK:        0001789192
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001493152-24-039126
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.03, 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

N2OFF enters €6M credit facility, pursues spin-off and drug discovery acquisition
--------------------------------------------------------------------------------

- €6M non-recourse credit facility at 7% interest; warrant for 1.85M shares at $1.00 exercise price.
- Board approved potential spin-off of cleantech units NTWO OFF and Save Foods into separate public company; N2OFF to retain ≥75% in Save Foods.
- Non-binding LOI to acquire a computationally advanced drug discovery company at valuation of at least $5M (possible $2M increase).
- Acquisition consideration would be cash and equity; company intends to tap new pharmaceutical market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789192/000149315224039126/0001493152-24-039126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789192/000149315224039126/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer